Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani

European Journal of Immunology

Volumn 28, Issue 2, 1998, Pages 669-680

  Engwerda, Christian R ^a   Murphy, Michaela L ^a   Cotterell, Sara E J ^a   Smelt, Sara C ^a   Kaye, Paul M ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

IL 12; Immunopathology; Leishmania

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; FEMALE; IMMUNOHISTOCHEMISTRY; LEISHMANIA DONOVANI; LIVER; MOUSE; NONHUMAN; PARASITE IMMUNITY; PRIORITY JOURNAL; SPLEEN; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIBODIES, MONOCLONAL; CRICETINAE; CYTOKINES; FEMALE; HOST-PARASITE RELATIONS; IMMUNITY, NATURAL; INTERLEUKIN-12; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIVER; MESOCRICETUS; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; ORGAN SPECIFICITY; SPECIES SPECIFICITY; SPLEEN; TH1 CELLS; TH2 CELLS;

EID: 0031937065     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199802)28:02<669::AID-IMMU669>3.0.CO;2-N     Document Type: Article

References (41)

1. Liew, F. Y. and O'Donnell, C. A., Immunology of leishmaniasis. Adv. Parasitol. 1993. 32: 161-259.
2. Veress, B., Malik, O. A., Satir, A. A. and el-Hassan, A. M., Morphological observations on visceral leishmaniasis in the Sudan. Trop. Geogr. Med. 1974. 26: 198-203.
3. Khaldi, R, Achouri, E., Gharbi, A., Debbabi, A. and Ben Naceur, H., Visceral leishmaniasis in children. A study of hospitalized cases from 1974 to 1988 at the Children's Hospital in Tunis. Med. Trop. (Mars.) 1991. 51: 143-148.
4. Wilson, M. E., Sandor, M., Blum, A. M., Young, B. M., Metwali, A., Elliott, D., Lynch, R. G. and Weinstock, J. V., Local suppression of IFN-gamma in hepatic granulomas correlates with tissue-specific replication of Leishmania chagasi. J. Immunol. 1996. 156: 2231-2239.
5. Khaldi, F., Bennaceur, B., Ben Othman, H., Achouri, E., Ayachi, R. and Regaieg, R., Severe forms of liver involvement in visceral leishmaniasis. Apropos of 7 cases. Arch. Fr. Pediatr. 1990. 47: 257-260.
6. Veress, B., Omer, A., Satar, A. A. and Hassan, A. M., Morphology of the spleen and lymph nodes in fatal visceral leishmaniasis. Immunology 1977. 33: 607-610.
7. McElrath, M. J., Murray, H. W. and Cohn, Z. A., The dynamics of granuloma formation in experimental visceral leishmaniasis. J. Exp. Med. 1988. 167: 1927-1937.
8. Kaye, P. M., Leishmaniasis: Immunology, persistence and antigen presentation. Baillieres Clin. Infect. Dis. 1994. 1: 351-366.
9. Murray, H. W., Squires, K. E., Miralles, C. D., Stoeckle, M. Y., Granger, A. M., Granelli Piperno, A. and Bogdan, C., Acquired resistance and granuloma formation in experimental visceral leishmaniasis. Differential T cell and lymphokine roles in initial versus established immunity. J. Immunol. 1992. 148: 1858-1863.
10. Murray, H. W., Endogenous interleukin-12 regulates acquired resistance in experimental visceral leishmaniasis. J. Infect. Dis. 1997. 175: 1477-1479.
11. Smelt, S. C., Engwerda, C. R., McCrossen, M. and Kaye, P. M., Destruction of follicular dendritic cells during chronic visceral leishmaniasis. J. Immunol. 1997. 158: 3813-3821.
12. Saha, B., Nanda-Roy, H., Pakrashi, A., Chakrabarti, R. N. and Roy, S., Immunobiological studies on experimental visceral leishmaniasis. I. Changes in lymphoid organs and their possible role in pathogenesis. Eur. J. Immunol. 1991. 21: 577-581.
13. Murray, H. W. and Hariprashad, J., Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis. J. Exp. Med. 1995. 181: 387-391.
14. Ghalib, H. W., Whittle, J. A., Kubin, M., Hashim, F. A., El-Hassan, A. M., Grabstein, K. H., Trinchieri, G. and Reed, S. G., IL-12 enhances Th1-type responses in human Leishmania donovani infections. J. Immunol. 1995. 154: 4623-4629.
15. Trinchieri, G., Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 1995. 13: 251-276.
16. Flynn, J. L., Goldstein, M. M., Triebold, K. J., Sypek, J., Wolf, S. and Bloom, B. R., IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection. J. Immunol. 1995. 155: 2515-2524.
17. Tripp, C. S., Gately, M. K., Hakimi, J., Ling, P. and Unanue, E. R., Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice. Reversal by IFN-gamma. J. Immunol. 1994. 152: 1883-1887.
18. Gazzinelli, R. T., Hieny, S., Wynn, T. A., Wolf, S. and Sher, A., Interleukin 12 is required for the T-lymphocyte-independent induction of Interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 1993. 90: 6115-6119.
19. Khan, I. A., Matsura, Y. and Kasper, L. H., Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect. Immun. 1994. 62: 1639-1642.
20. Hunter, C. A., Subauste, C. S., Van Cleave, V. H. and Remington, J. S., Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect. Immun. 1994. 62: 2818-2824.
21. Clemons, K. V., Brummer, E. and Stevens, D. A., Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob. Agents Chemother. 1994. 38: 460-464.
22. Murray, H. W., Hariprashad, J. and Coffman, R. L., Behavior of visceral Leishmania donovani in an experimentally induced T helper cell 2 (Th2)-associated response model. J. Exp. Med. 1997. 185: 867-874.
23. Taylor, A. P. and Murray, H. W., Intracellular antimicrobial activity in the absence of interferon-gamma: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-gamma gene-disrupted mice. J. Exp. Med. 1997. 185: 1231-1239.
24. Sypek, J. P., Chung, C. L., Mayor, S. E. H., Subramanyam, J. M., Goldman, S. J., Sieburth, D. S., Wolf, S. and Schaub, R. G., Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 1993. 177: 1797-1802.
25. Heinzel, F. P., Schoenhaut, D. S., Rerko, R. M., Rosser, L. E. and Gately, M. K., Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 1993. 177: 1505-1509.
26. Engwerda, C. R., Smelt, S. C. and Kaye, P. M., An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice. Exp. Parasitol. 1996. 84: 195-202.
27. Bradley, D. J., Taylor, B. A., Blackwell, J. M., Evans, E. P. and Freeman, J., Regulation of Leishmania populations within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse. Clin. Exp. Immunol. 1979. 37: 7-14.
28. Bradley, D. J., Regulation of Leishmania populations within the host. II. Genetic control of acute susceptibility of mice to Leishmania donovani infection. Clin. Exp. Immunol. 1977. 30: 130-140.
29. Magram, J., Connaughton, S. E., Warrier, R. R., Carvajal, D. M., Wu, C. Y., Ferrante, J., Stewart, C., Sarmiento, U., Faherty, D. A. and Gately, M. K., IL-12-deficient mice are defective in IFN-gamma production and type 1 cytokine responses. Immunity 1996. 4: 471-481.
30. Scharton-Kersten, T., Afonso, L. C., Wysocka, M., Trinchieri, G. and Scott, P., IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 1995. 154: 5320-5330.
31. Squires, K. E., Schreiber, R. D., McElrath, M. J., Rubin, B. Y., Anderson, S. L. and Murray, H. W., Experimental visceral leishmaniasis: role of endogenous IFN-gamma in host defense and tissue granulomatous response. J. Immunol. 1989. 143: 4244-4249.
32. Blackwell, J. M., Barton, C. H., White, J. K., Roach, T. I., Shaw, M. A., Whitehead, S. H., Mock, B. A., Searle, S., Williams, H. and Baker, A. M., Genetic regulation of leishmanial and mycobacterial infections: the Lsh/Ity/Beg gene story continues, Immunol. Lett. 1994. 43: 99-107.
33. Bradley, D. J. and Kirkley, J., Regulation of Leishmania populations within the host. I. The variable course of Leishmania donovani infections in mice. Clin. Exp. Immunol. 1977. 30: 119-129.
34. Crocker, P. R., Blackwell, J. M. and Bradley, D. J., Transfer of innate resistance and susceptibility to Leishmania donovani infection in mouse radiation bone marrow chimaeras. Immunology 1984. 52: 417-422.
35. Crocker, P. R., Blackwell, J. M. and Bradley, D. J., Expression of the natural resistance gene Lsh in resident liver macrophages. Infect. Immun. 1984. 43: 1033-1040.
36. Vidai, S., Tremblay, M. L., Govoni, G., Gauthier, S., Sebastiani, G., Malo, D., Skamene, E., Olivier, M., Jothy, S. and Gros, P., The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp 1 gene. J. Exp. Med. 1995. 182: 655-666.
37. Kirkpatrick, C. E. and Farrell, J. P., Leishmaniasis in beige mice. Infect. Immun. 1982. 38: 1208-1216.
38. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 1993. 178: 567-577.
39. Kaye, P. M., Curry, A. J. and Blackwell, J. M., Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J. Immunol. 1991. 146: 2763-2770.
40. Wysocka, M., Kubin, M., Vieira, L. Q., Ozmen, L., Garotta, G., Scott, P. and Trinchieri, G., Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. Eur. J. Immunol. 1995. 25: 672-676.
41. Stenger, S., Thuring, H., Röllinghoff, M. and Bogdan, C., Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 1994. 180: 783-793.